Skip to content

Zenas BioPharma (ZBIO) IPO deck

Zenas BioPharma is a clinical-stage global biopharmaceutical company developing innovative immune-based therapies for autoimmune diseases, with a focus on advancing first- and best-in-class therapeutics like Obexelimab.

This post is for subscribers only

Subscribe

Already have an account? Sign In

Latest